Trial intelligence / Profile preview

TAP Block vs Caudal Dexmedetomidine in Pediatric Abdominal Surgery

NCT06183073Phase 2Recruiting

Sponsor
Sohag University
Start
Apr 2023
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoint: 1st analgesic requirement at 12 hours. Started Apr 2023; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06183073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06183073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call